Interestingly, in most of these cancers, the loss of ATRX is intimately linked to the alternative lengthening of telomeres (ALT), a unique homologous recombination-based telomere maintenance mechanism that contributes to cellular immortality in cancer [65,74,75,76,77]. This evidence concerns the gene GPT and cancer.